156 related articles for article (PubMed ID: 4769481)
21. Phenformin and vascular complications of diabetes.
Med Lett Drugs Ther; 1972 Jan; 14(1):1-2. PubMed ID: 4567560
[No Abstract] [Full Text] [Related]
22. Oral hypoglycaemic agents.
Med J Aust; 1973 Mar; 1(12):570-1. PubMed ID: 4700542
[No Abstract] [Full Text] [Related]
23. Comments on the UGDP study.
Schöffling K
Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
[No Abstract] [Full Text] [Related]
24. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
[No Abstract] [Full Text] [Related]
25. [Tolbutamide and coronary heart disease].
Paasikivi J
Duodecim; 1971; 87(21):1405-8. PubMed ID: 5114598
[No Abstract] [Full Text] [Related]
26. Diabetic hearts and biguanides.
Biron P
Can Med Assoc J; 1975 Aug; 113(3):175-6. PubMed ID: 166752
[No Abstract] [Full Text] [Related]
27. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
[No Abstract] [Full Text] [Related]
28. The UGDP--tolbutamide and mortality.
Knowles HC
Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
[No Abstract] [Full Text] [Related]
29. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
Meinert CL; Knatterud GL; Prout TE; Klimt CR
Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
[No Abstract] [Full Text] [Related]
30. [Attack after oral antidiabetics].
Frey H
Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2097-8. PubMed ID: 5479224
[No Abstract] [Full Text] [Related]
31. Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
Goetz FC
Postgrad Med; 1972 Jul; 52(1):63-8. PubMed ID: 5067890
[No Abstract] [Full Text] [Related]
32. [Evaluation of oral hypoglycemic agents following the University Group of Diabetes Program].
Sasaki A
Nihon Rinsho; 1977 Feb; 35(2):317-23. PubMed ID: 558370
[No Abstract] [Full Text] [Related]
33. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
[No Abstract] [Full Text] [Related]
34. Farewell to phenformin for treating diabetes mellitus.
Williams RH; Palmer JP
Ann Intern Med; 1975 Oct; 83(4):567-8. PubMed ID: 1166991
[No Abstract] [Full Text] [Related]
35. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
Teuscher A
Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
[No Abstract] [Full Text] [Related]
36. [Clinical testing of Tolbutaphen in the treatment of adult diabetes].
Schneider J; Kaffarnik H
Z Allgemeinmed; 1975 Jan; 51(2):74-5. PubMed ID: 766424
[No Abstract] [Full Text] [Related]
37. [Increased risk of cardiovascular complications with oral hypoglycemic agents?].
Mueller R
Acta Diabetol Lat; 1970; 7(5):805-23. PubMed ID: 4949515
[No Abstract] [Full Text] [Related]
38. An historical view of the medical-social aspects of the UGDP.
Knowles HC
Trans Am Clin Climatol Assoc; 1977; 88():150-6. PubMed ID: 898533
[No Abstract] [Full Text] [Related]
39. [Letter: Oral antidiabetics and cardiovascular disorders].
Ned Tijdschr Geneeskd; 1975 Nov; 119(44):1731-2. PubMed ID: 1214880
[No Abstract] [Full Text] [Related]
40. [Controlled clinical study of a new oral antidiabetic formed by a glibenclamide-phenformin association].
Torri A; Zanni A
Clin Ter; 1974 Aug; 70(3):236-57. PubMed ID: 4214456
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
